FEN1 and prostate carcinoma: In addition, FEN1 overexpression reduced the proportion of S phase cells (20.47 ± 1.65%) compared to the LNCaP‐FEN1‐KD group.The results indicated that DTX induced S‐phase arrest in prostate cancer cells, which could be partially reversed by FEN1 overexpression.